Key financial ranges
Market cap · USD equivalent
P/E ratio
Annual revenue · USD equivalent
Revenue growth
Valuation & profitability
Price / sales
Annual net income · USD equivalent
Net profit margin
Cash & debt
Cash · USD equivalent
Total debt · USD equivalent
Net cash · USD equivalent
Debt / revenue
| Company | Market cap | P/E | Revenue | Rev. growth | Net income | Cash | Debt | AI value |
|---|---|---|---|---|---|---|---|---|
| ARCCAres Capital Corp | $14.41B | 14.9× | $3.05B | +2.1% | $1.3B | $505M | $15.85B | Fair valued |
| MASMasco Corp | $14.4B | 16.8× | $7.56B | -3.4% | $810M | $388M | $3.17B | Fair valued |
| LOGILogitech International S.a. | $14.38B | 19.1× | $4.84B | +6.3% | $711.19M | $1.75B | $84.39M | Fair valued |
| CPTCamden Property Trust | $14.34B | 35.1× | $12.97M | +81.7% | $384.46M | $44.72M | $5.47B | Fair valued |
| JBSJbs N.v. | $14.29B | 12.5× | $86.18B | +11.7% | $2.23B | $4.57B | $1.96B | Fair valued |
| OHIOmega Healthcare Investors Inc | $14.23B | 16.8× | $1.19B | +13.2% | $590.19M | $39.04M | $4.29B | Fair valued |
| MKCMccormick & Co Inc | $14.1B | 8.7× | $6.84B | +1.7% | $789.4M | $331.2M | $4.93B | Fair valued |
| MLIMueller Industries Inc | $14.09B | 16.6× | $4.18B | +10.9% | $765.19M | $1.39B | $24.68M | Fair valued |
| AIZAssurant, Inc. | $14.09B | 13.6× | $12.81B | +7.9% | $872.7M | $1.7B | $73.9M | Fair valued |
| FIVEFive Below, Inc | $14.09B | 22.9× | $4.76B | +22.9% | $358.64M | $561.08M | $2.04B | Overvalued |
| CSLCarlisle Companies Inc | $14.04B | 20.1× | $5.02B | +0.3% | $740.7M | $665.3M | $2.89B | Fair valued |
| HLHecla Mining Co | $14.02B | 26.8× | $1.42B | +53.0% | $321.71M | $483.48M | $21.48M | Overvalued |
| QXOQXO, Inc. | $14.02B | — | $6.84B | +11,925.0% | -$279.4M | $2.77B | $7.03B | Fair valued |
| CHKPCheck Point Software Technologies Ltd | $14B | 14.0× | $2.73B | +6.3% | $1.06B | $1.8B | $34.6M | Undervalued |
| TRMBTrimble Inc. | $13.98B | — | $3.59B | -2.6% | $424M | $214.4M | $1.46B | Fair valued |
| REGRegency Centers Corp | $13.91B | 25.6× | $1.55B | +6.9% | $527.46M | $145.56M | $5.24B | Fair valued |
| GRABGrab Holdings Ltd | $13.91B | 24.6× | $3.37B | +20.5% | $200M | $3.43B | $2.29B | Fair valued |
| CACICaci International Inc | $13.9B | 26.0× | $9.57B | +10.9% | $535.81M | $191.76M | $5.38B | Fair valued |
| CRLCharles River Laboratories International, Inc. | $13.87B | — | $4.02B | -0.9% | -$144.34M | $192.03M | $3.03B | Overvalued |
| RNRRenaissancere Holdings Ltd | $13.84B | 5.7× | $12.85B | +9.9% | $2.68B | $1.3B | $2.33B | Fair valued |